Towards safe nanoparticle technologies for nucleic acid therapeutics

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Molecular Biology

Background:

• Nucleic acid therapeutics, including gene therapy, have historically faced challenges in achieving their therapeutic potential.
• Efficient and safe delivery of functional nucleic acids in vivo remains a critical hurdle for widespread clinical adoption.

Purpose of the Study:

• To review progress in developing safe nanoparticles for efficient in vivo delivery of nucleic acid therapeutics.
• To highlight the role of chemistry in advancing nanotechnology for nucleic acid delivery.
• To discuss the potential of these advancements for treating diseases, especially cancers.

Main Methods:

• Review of research and development in nanoparticle-based nucleic acid delivery systems.
• Focus on work from the Imperial College Genetic Therapies Centre and collaborations.
• Emphasis on chemical advancements in the design and formulation of nanotechnologies.

Main Results:

• Demonstration of progress from early animal models to current preclinical/clinical advancements.
• Identification of new chemistry as central to creating safe and effective nanodelivery systems.
• Evidence suggesting that improved delivery technologies are overcoming past limitations.

Conclusions:

• Nanoparticle delivery technologies are crucial for realizing the promise of nucleic acid therapeutics.
• Chemistry plays a pivotal role in developing safer and more effective nanotherapies.
• These advancements hold significant potential for novel cancer therapies and cures.